• LifeCell has partnered with renowned financial institutions such as Bajaj Finserv and LiquiLoans to offer a range of flexible zero-interest EMI plans to parents across the country
• Plan options available where parents pay nothing or INR 1 as down payment
• LifeCell's diverse range of finance options ensure accessibility and affordability for anyone seeking to preserve their baby's stem cells

MUMBAI, India, June 8, 2023 /PRNewswire/ --  LifeCell International, a pioneering provider of genetic screening and cell-and tissue-based therapeutics, has launched a range of innovative finance options in partnership with renowned financial institutions, such as Bajaj Finserv and LiquiLoans. Parents can now avail LifeCell's umbilical cord blood banking service by paying as little as zero or INR 1 as down payment, with affordable, interest-free monthly installments. LifeCell has also introduced the Buy Now Pay Later plan, where parents only have to pay three out of six EMIs, starting from the fourth month, with only loan processing fees to be paid during the first three months.

The plans are designed to mitigate the financial burden for families across the country looking to preserve their babies' valuable umbilical cord stem cells, and offer them convenient choices for enrolling in stem cell banking.

Sumanth Sarangapani, CEO, LifeCell International Pvt Ltd, expressed his enthusiasm about the new finance options, said, "Pregnancy is a very joyous, yet challenging, time for families, as they prepare for the arrival of their babies and ensure they are doing everything to care for and protect them. At the same time, taking steps to preserve their infants' umbilical cord blood is also critical, given the role stem cells can play in securing a healthy future for them and their family members. Considering how mentally and financially stressful this time can be, we wanted to do whatever we could, to simplify the process and reduce their out-of-pocket expense for umbilical cord blood banking.

By offering zero-interest EMI plans and a range of flexible tenure options, we have made stem cell banking affordable, convenient, and within reach for families across India. We believe that no parent should have to compromise on their child's future due to financial constraints."

Highlights of LifeCell's new financing options

Umbilical cord blood banking has gained widespread recognition in recent years due to the immense potential of derived stem cells in treating over 90 medical conditions such as inherited blood disorders, metabolic disorders, immune disorders, blood cancers, etc. Transplant of umbilical cord stem cells also requires adherence to fewer HLA matching criteria, as compared to bone marrow transplants. This makes them the perfect candidate for future use in case the need for treatment arises.

LifeCell is the first Indian stem cell storage bank that adheres to the Indian Paediatric Association's recommendation to adopt a hybrid banking model, called community banking, which makes the stem cell repository available for use by the specific family as well as others in the community who may require stem cells and demonstrate a match. Currently, LifeCell is the largest registry of Indian origin stem cells, with over 60,000 preserved cord blood units. The company offers unlimited stem cell retrievals for the entire family at the cost of one enrolment, and is the only stem cell bank to undertake genomic profiling of the stem cell units before transplant, to enhance patient safety. To further ensure long-term protection for families, LifeCell offers disaster-proof dual-site storage facilities.

For more details about the new finance plans, please visit https://products.lifecell.in/lc-nodownpayment?utm_source=PR&utm_medium=PressRelease&utm_campaign=EMI

About LifeCell International Pvt Ltd

LifeCell International, founded in 2004 in Chennai, is India's premier healthcare services provider, leveraging advanced technologies such as stem cells & genomics towards addressing the country's current & future health needs.

LifeCell's Community Banking Program offers the world's largest repository of ready-to-use access to over 70,000+ matching stem cell units for Indian-origin patients seeking a transplant. Its facilities are AABB, NABL & CAP accredited.

In addition, LifeCell offers cell and tissue-based biologics for various conditions, including advanced wound care, surgical recovery, regenerative medicine, & more. Its manufacturing facilities are authorized by DCGI and AATB accredited, ensuring the highest quality & safety standards.

It also provides special health investigations for patients seeking discreet self-service offerings from the comfort of their homes through mail-order test kits that cover a range of conditions, including fertility, sexual & general health.

Committed to improving health outcomes by providing preventive & definitive diagnoses, LifeCell is working relentlessly to help every child & family live their healthiest lives.

For more details, please visit: www.lifecell.in

View original content:https://www.prnewswire.com/in/news-releases/zero-interest-emis-1-rupee-down-payment-lifecell-makes-stem-cell-banking-affordable-for-all-301845961.html